Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00128284 · ClinicalTrials.gov registry record

A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time

A clinical trial of Gastroparesis and Gastrointestinal Diseases, sponsored by The SmartPill Corporation.

Completed
Registry status
148
Enrollment target
7
Study locations

NCT00128284 is a study of Gastroparesis and Gastrointestinal Diseases that has completed, run by The SmartPill Corporation. The registered enrollment target is 148 participants, below the 299-participant average among 44 other Gastroparesis trials with a reported enrollment target (51% lower). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00128284, a study of Gastroparesis and Gastrointestinal Diseases, has completed, sponsored by The SmartPill Corporation.

COMPLETED
Registry status
148 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to determine the correlation between gastric residence time of the SmartPill Capsule and the time required for partial emptying of a standard radiolabeled meal as measured by gastric emptying scintigraphy.

Study Locations (7)

Kansas

  • Division of Gastroenterology and Hepatology at KUMC - Kansas City

Kentucky

  • University of Louisville Medical Center - Louisville

Massachusetts

  • Massachusetts General Hospital - Boston

Michigan

  • University of Michigan Medical Center - Ann Arbor

New York

  • VA Medical Center - Buffalo

North Carolina

  • Wake Forest University Baptist Medical Center - Winston-Salem

Pennsylvania

  • Temple University Medical Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2005-02
Est. Completion 2005-10

Sponsor

The SmartPill Corporation

3 total trials

What the Registry Record Tells You About NCT00128284

The ClinicalTrials.gov registry entry for NCT00128284 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 299-participant average among 44 other Gastroparesis trials with a reported enrollment target (51% lower). The listed sponsor is The SmartPill Corporation, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Gastroparesis appearing as the primary indexed condition, and to 0 interventions.

NCT00128284 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Kansas, Kentucky, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00128284 about?

NCT00128284 is a clinical study titled "A Comparison of SmartPill Capsule With Scintigraphy for Determining Gastric Residence Time". The purpose of this study is to determine the correlation between gastric residence time of the SmartPill Capsule and the time required for partial emptying of a standard radiolabeled meal as measured by gastric emptying scintigraphy.

What is the current status of trial NCT00128284?

This trial is currently completed. The enrollment target is 148 participants. The study started on 2005-02. Estimated completion is 2005-10.

What conditions does trial NCT00128284 study?

This clinical trial studies the following conditions: Gastroparesis, Gastrointestinal Diseases, Stomach Diseases.

Who is sponsoring clinical trial NCT00128284?

This trial is sponsored by The SmartPill Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00128284 being conducted?

This trial has 7 study locations across Kansas, Kentucky, Massachusetts, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.